← Back to guidelines
Critical Care103 papers

End stage renal failure on dialysis

Last edited: 4/15/2026

Overview

End-stage renal failure (ESRF) on dialysis represents the final stage of chronic kidney disease where renal function is severely compromised, necessitating dialysis for survival. Patients often face complex medical management and require multidisciplinary care to address comorbidities and quality of life issues 13.

Diagnosis

  • Clinical Criteria: Presence of kidney failure with estimated glomerular filtration rate (eGFR) <15 mL/min/1.73 m2 1.
  • Laboratory Tests: Regular monitoring of serum creatinine, blood urea nitrogen (BUN), electrolytes, and complete blood count 1.
  • Imaging: Not typically required for diagnosis but may be used to assess complications 1.
  • Special Considerations: Evaluation for life-limiting conditions such as cancer, dementia, or other organ failures 1.
  • Management

  • Dialysis: Regular hemodialysis or peritoneal dialysis to manage fluid balance and waste removal 1.
  • Nutritional Support: Tailored dietary interventions to manage protein intake and electrolyte balance 1.
  • Medication Management: Control of hypertension, anemia, bone disease, and other complications with appropriate drug classes (e.g., erythropoietin-stimulating agents, phosphate binders) 1.
  • Hospice Care: Consideration for hospice services to improve quality of life in advanced stages 3.
  • Psychosocial Support: Addressing mental health, particularly depression, which may improve with specialized care 2.
  • End-of-Life Care: Balancing necessary treatments with potentially burdensome interventions, ensuring access to palliative care 1.
  • Special Populations

  • Comorbidities: Patients with ESRF often have coexisting conditions like obesity, requiring careful evaluation for interventions such as bariatric surgery, which can be beneficial despite organ failure 2.
  • Hospice Referral: Special considerations for coding and billing for specialist services in patients enrolled in hospice programs, ensuring appropriate utilization of Medicare hospice benefits 3.
  • Key Recommendations

  • Evaluate and Manage Comorbidities: Regular assessment and management of comorbidities, including consideration for obesity surgery in selected patients with ESRF, to improve overall outcomes (Evidence: Moderate 2).
  • Integrate Hospice Services: Facilitate timely referral to hospice care to enhance quality of life and manage end-of-life care effectively (Evidence: Moderate 3).
  • Balance Treatment Burden: Carefully weigh the necessity of treatments against potential burdens, ensuring access to necessary palliative care services (Evidence: Expert opinion 1).
  • References

    1 Nicholas LH, Fischer SM, Arbaje AI, Perraillon MC, Jones CD, Polsky D. Medicare-Covered Services Near the End of Life in Medicare Advantage vs Traditional Medicare. JAMA health forum 2024. link 2 Billeter AT, Zumkeller M, Brock J, Herth F, Zech U, Zeier M et al.. Obesity surgery in patients with end-stage organ failure: Is it worth it?. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2022. link 3 Moore S, von Gunten CF. Pulmonary/Critical care physicians and hospice patients: billing specialty care for patients enrolled in a hospice program. Chest 2010. link

    Original source

    1. [1]
      Medicare-Covered Services Near the End of Life in Medicare Advantage vs Traditional Medicare.Nicholas LH, Fischer SM, Arbaje AI, Perraillon MC, Jones CD, Polsky D JAMA health forum (2024)
    2. [2]
      Obesity surgery in patients with end-stage organ failure: Is it worth it?Billeter AT, Zumkeller M, Brock J, Herth F, Zech U, Zeier M et al. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery (2022)
    3. [3]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG